AIF, IN (Apoptosis Inducing Factor) (Blocking Peptide), Purified

AIF, IN (Apoptosis Inducing Factor) (Blocking Peptide), Purified
Item number Size Datasheet Manual SDS Delivery time Quantity Price
A1059-75P.50 50 µg - -

9 - 20 business days*

459.00€
 
Peptide corresponding to amino acids 517 to 531 of human AIF (2).|Apoptosis is characterized by... more
Product information "AIF, IN (Apoptosis Inducing Factor) (Blocking Peptide), Purified"
Peptide corresponding to amino acids 517 to 531 of human AIF (2)., Apoptosis is characterized by several morphological nuclear changes including chromatin condensation and nuclear fragmentation. These changes are triggered by the activation of members of caspase family, caspase activated DNase, and several novel proteins (1). A novel gene, the product of which causes chromatin condensation and DNA fragmentation, was recently identified, cloned, and designated apoptosis inducing factor (AIF) (2). Like the critical molecules, cytochrome c and caspase-9, in apoptosis, AIF localizes in mitochondria. AIF translocates to the nucleus when apoptosis is induced and induces mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. AIF induces chromatin condensation and DNA fragmentation, which are the hallmarks of apoptosis, of the isolated nucleus and the nucleus in live cells by microinjection. AIF is highly conserved between human and mouse and widely expressed (2).
Supplier: United States Biological
Supplier-Nr: A1059-75P

Properties

Conjugate: No
Format: Purified

Database Information

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "AIF, IN (Apoptosis Inducing Factor) (Blocking Peptide), Purified"
Write a review
or to review a product.
Viewed